Presentation of AC-1101 case study results at the 2nd Dermatology Drug Development Summit Europe in Frankfurt, Germany

TWiB will present the latest development of AC-1101 project (JAK inhibitor) for vitiligo and atopic dermatitis at the upcoming 2nd Dermatology Drug Development Summit Europe , Frankfurt, Germany. 

  The event was postponed until further notice due to the current COVID-19 situation.